Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling
Abstract. Chronic lymphocytic leukemia (CLL) is characterized by an acquired immune dysfunction, which may underlie the hampered efficacy of cellular immunotherapy. Most data on dampened immune responses in CLL come from studies investigating CLL and T cell interactions. Natural killer (NK) cells ma...
Main Authors: | Tom Hofland, Sanne Endstra, Calum K.P. Gomes, Renate de Boer, Iris de Weerdt, Vladimir Bobkov, Jurgen A. Riedl, Raimond Heukers, Martine J. Smit, Eric Eldering, Mark-David Levin, Arnon P. Kater, Sanne H. Tonino |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2019-12-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000308 |
Similar Items
-
Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia
by: Tom Hofland, et al.
Published: (2019-09-01) -
Functional Differences Between EBV- and CMV-Specific CD8+ T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL
by: Tom Hofland, et al.
Published: (2020-04-01) -
Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing?
by: Marco V. Haselager, et al.
Published: (2020-10-01) -
Hypo-efficient domination and hypo-unique domination
by: V. Samodivkin
Published: (2016-06-01) -
Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma
by: Jaco A. C. van Bruggen, et al.
Published: (2020-12-01)